Sinopharm (XKP) vaccines, i.e., the manufacturer is China National Pharmaceutical Group (Sinopharm), including the vaccine produced by Wuhan Biologicals and the vaccine produced by Beijing Biologicals, both of which are inactivated vaccines. The development process of inactivated virus vaccines is mainly through the culture of viruses on cellular substrates, and then kill the infectious viruses by physical or chemical methods, but at the same time maintain the integrity of their antigenic particles, so as to make them lose their pathogenicity while retaining their antigenicity. Inactivated vaccines are technically mature, with good safety and clear side effects, and are suitable for universal vaccination. The results of phase III clinical trials conducted in the United Arab Emirates and other countries show that the vaccine is 72.51% effective in protecting against diseases caused by the new coronavirus infection after two shots of the immunization program. The immunization program of Sinopharm’s Beijing Bio-Xin Guan Pneumonia Vaccine showed that after two injections of the vaccine, the vaccine’s protective effect against diseases caused by Xin Guan Virus infection was 79.34%. For the sake of their own health and epidemic prevention and control, please timely vaccination of the new coronavirus pneumonia vaccine, Sinopharm vaccine and Kexing vaccine and other vaccines are not very different, before the vaccination consult the vaccination point of the physician, to rule out contraindications to vaccination, after the vaccination to stay half an hour, after going home to pay attention to observe whether there is any discomfort. [Tip] This article refers to “new coronary pneumonia, new coronary virus pneumonia”, etc., has been December 26, 2022, the National Health Commission issued a notice to change the name to “new coronary virus infection”.